Gladstone Institutional Advisory’s iShares Biotechnology ETF IBB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$495K Buy
3,909
+254
+7% +$32.1K 0.02% 496
2025
Q1
$468K Sell
3,655
-216
-6% -$27.6K 0.02% 485
2024
Q4
$512K Sell
3,871
-520
-12% -$68.8K 0.02% 468
2024
Q3
$639K Sell
4,391
-977
-18% -$142K 0.03% 395
2024
Q2
$737K Sell
5,368
-63
-1% -$8.65K 0.04% 352
2024
Q1
$745K Sell
5,431
-885
-14% -$121K 0.04% 333
2023
Q4
$858K Buy
6,316
+420
+7% +$57.1K 0.05% 315
2023
Q3
$721K Buy
5,896
+49
+0.8% +$5.99K 0.05% 322
2023
Q2
$742K Sell
5,847
-639
-10% -$81.1K 0.05% 328
2023
Q1
$838K Sell
6,486
-388
-6% -$50.1K 0.05% 321
2022
Q4
$903K Sell
6,874
-1,289
-16% -$169K 0.06% 294
2022
Q3
$955K Sell
8,163
-359
-4% -$42K 0.07% 275
2022
Q2
$1M Buy
8,522
+131
+2% +$15.4K 0.08% 271
2022
Q1
$1.09M Sell
8,391
-4,879
-37% -$636K 0.07% 280
2021
Q4
$2.03M Buy
13,270
+1,988
+18% +$303K 0.16% 174
2021
Q3
$1.82M Sell
11,282
-222
-2% -$35.9K 0.18% 151
2021
Q2
$1.88M Buy
11,504
+153
+1% +$25K 0.22% 112
2021
Q1
$1.71M Buy
11,351
+5,641
+99% +$849K 0.27% 94
2020
Q4
$865K Sell
5,710
-50
-0.9% -$7.57K 0.17% 116
2020
Q3
$780K Buy
5,760
+340
+6% +$46K 0.19% 111
2020
Q2
$741K Buy
5,420
+668
+14% +$91.3K 0.19% 104
2020
Q1
$512K Buy
4,752
+1,749
+58% +$188K 0.13% 138
2019
Q4
$362K Sell
3,003
-67
-2% -$8.08K 0.09% 171
2019
Q3
$306K Sell
3,070
-1,681
-35% -$168K 0.08% 202
2019
Q2
$518K Buy
4,751
+1,428
+43% +$156K 0.16% 131
2019
Q1
$372K Buy
3,323
+269
+9% +$30.1K 0.14% 138
2018
Q4
$294K Buy
+3,054
New +$294K 0.17% 129